Perfromance Wealth Partners, LLC Moderna, Inc. Transaction History

Perfromance Wealth Partners, LLC

  • $2.89 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
BUY
$101.21 - $166.61 $202,420 - $333,220
2,000 New
2,000 $237,000
Q1 2023

Apr 20, 2023
SELL
$135.66 - $197.02 $149,361 - $216,919
-1,101 Reduced 42.18%
1,509 $231,000
Q4 2022

Jan 19, 2023
BUY
$118.38 - $210.04 $47,352 - $84,016
400 Added 18.1%
2,610 $0
Q3 2022

Oct 17, 2022
SELL
$118.07 - $194.18 $82,649 - $135,926
-700 Reduced 24.05%
2,210 $261,000
Q1 2022

Apr 21, 2022
BUY
$126.46 - $235.05 $151,752 - $282,060
1,200 Added 70.18%
2,910 $501,000
Q4 2021

Feb 03, 2022
BUY
$225.82 - $368.51 $386,152 - $630,152
1,710 New
1,710 $434,000

Others Institutions Holding MRNA

# of Institutions
1,022
Shares Held
242M
Call Options Held
9.07M
Put Options Held
13.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $19.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Perfromance Wealth Partners, LLC Portfolio

Follow Perfromance Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email